Table 2. Endonuclease inhibition (FRET), anti-viral effect (CPE), cytotoxic dose and thermo-stabilisation (Tm) of pH1N1 PA-Nter by diketo compounds and EGCG.
Compound | FRETa IC50 [µM] | antiviral activity IC50 [µM]b | CC50c [µM] | Tme [°C] |
none | - | - | - | 53.5 |
DPBA | 2.7±0.3 | inactive | >200d | 65 |
R05-1 | 0.13±0.04 | 20.4±3.0 | >100d | 69 |
R05-2 | 0.06±0.02 | 15.9±4.0 | >50d | 71 |
R05-3 | 1.1±0.5 | 19.9±2.0 | 79.8±11.5 | 69 |
EGCG | 1.9±0.4 | 1.1±0.4 | 54.7±4.5 | ndf |
Fluorescence resonance energy transfer (FRET) based endonuclease activity assay. FRET measurements were determined in quadruplicates with at least two independent sets. Mean values and 95% confidence limits (as indicated) were calculated.
Reduction of virus induced cytopathic effect (CPE); inactive: no antiviral activity at the highest concentration tested. For CPE IC50 and CC50 values samples were applied in duplicates and IC50 values, CC50 values, and corresponding 95% confidence intervals were determined. The experiments were independently performed at least twice.
48 h cytotoxicity on MDCK cells.
No cytotoxicity at the highest concentration tested (mainly limited by solubility).
Apparent melting temperature Tm derived from Thermofluor measurements.
Not determined due to fluorescence quenching.